Your search returned 140 results.

Sort
Results
1.
Radioiodine Theranostics: Increasing Dialogue and Collaboration. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 28970353
Year: 2017
Citation:
  • Journal of Nuclear Medicine. 58(10):19N-20N, 2017 Oct
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
2.
Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31271271
Year: 2019
Citation:
  • The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Giovanella L, van Nostrand D
3.
I-131 dosimetry for differentiated thyroid cancer MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun 6
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
4.
The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun 6
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
5.
Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 32812307
Year: 2020
Citation:
  • Head & Neck. 2020 Aug 19
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Angelos P, Bernet V, Boucai L, Buchholzer S, Burkey B, Eisele D, Erkul E, Faure F, Freitag SK, Gillespie MB, Harrell RM, Hartl D, Haymart M, Leffert J, Mandel S, Marchal F, Miller BS, Morris J, Pearce EN, Rahmati R, Randolph G, Ryan WR, Schaitkin B, Schlumberger M, Singer MC, Stack BC, Van Nostrand D, Wong KK
6.
GU and thyroid cancer MedStar authors:
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2014.1_1
7.
I-131 remnant ablation and adjuvant treatment: an interactive program MedStar authors:
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2014.1_1
8.
I-131 dosimetry for differentiated thyroid cancer MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
9.
The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
10.
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30900516
Year: 2019
Citation:
  • Thyroid. 29(4):461-470, 2019 04.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA
11.
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 35649660
Year: 2022
Citation:
  • Journal of Nuclear Medicine. 63(6):15N-35N, 2022 Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Avram AM, Giovanella L, Greenspan B, Lawson SA, Luster M, Ovcaricek PP, Peacock JG, Silberstein E, Tulchinsky M, Van Nostrand D, Verburg FA, Vrachimis A
12.
Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30105931
Year: 2018
Citation:
  • Thyroid. 28(9):1083-1093, 2018 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
13.
I-131 dosimetry for differentiated thyroid cancer MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
14.
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31616967
Year: 2019
Citation:
  • European Journal of Nuclear Medicine & Molecular Imaging. 2019 Oct 15
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Flux G, Giovanella L, Luster M, Muylle K, van Nostrand D, Verburg FA
15.
Brief progress report from the intersocietal working group on differentiated thyroid cancer. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 32166513
Year: 2020
Citation:
  • European Journal of Nuclear Medicine & Molecular Imaging. 2020 Mar 12
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Bardies M, Bernet V, Bourguet P, Daniels GH, Draganescu C, Fuhrer-Sakel D, Greenspan B, Gulec S, Hegedus L, Jonklaas J, Luster M, Oyen W, Smit J, Tuttle RM, Van Nostrand D, Verburg FA, Zerdoud S
16.
David C. Moses, MD (1940-2020). MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 32499287
Year: 2020
Citation:
  • Journal of Nuclear Medicine. 61(6):20N, 2020 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
17.
Current use and controversies for I-131 in thyroid cancer MedStar authors:
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2014.1_1
18.
The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
19.
The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 29475999
Year: 2018
Citation:
  • Journal of Nuclear Medicine. 59(7):1017-1019, 2018 07.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Greenspan BS, Maurer AH, Phillips WT, Sacks B, Siegel JA, Silberstein EB, Taylor AT, Van Nostrand D
20.
Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer. [Review] MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 28760238
Year: 2017
Citation:
  • Endocrinology & Metabolism Clinics of North America. 46(3):783-793, 2017 Sep
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
21.
Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 29650270
Year: 2018
Citation:
  • Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D
22.
Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31160436
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
23.
Overview of the Martinique Meetings: What Has Been Established and Where Are We Going?. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31160431
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(6):15N, 2019 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Greenspan BS, Gulec S, Van Nostrand D
24.
Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31184275
Year: 2019
Citation:
  • Thyroid. 29(7):901-909, 2019 Jul.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
25.
The Martinique Principles. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31227575
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(9):1334-1335, 2019 09.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Dillehay G, Greenspan BS, Gulec S, Van Nostrand D
26.
I-131 dosimetry for differentiated thyroid cancer MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
27.
The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors:
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Van Nostrand D
Local accession number:
  • 2015_1
28.
Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer With Dabrafenib. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 37212326
Year: 2023
Citation:
  • Thyroid. 2023 May 22
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bach-Gansmo TI, Bogsrud TV, Castillejo M, Durski JM, Engelsen O, Haskjold OI, Jacobsen M, Larsen EP, Nostrand DV
29.
Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and <sup>123</sup>I for localization of rapid washout parathyroid adenomas. MedStar authors:
  • Kulkarni, Kanchan
  • Van Nostrand, Douglas
PMID:
  • 30706095
Year: 2019
Citation:
  • Osteoporosis International. 30(5):1051-1057, 2019 May.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Kulkarni K, Kushchayev SV, Kushchayeva YS, Tella SH, Van Nostrand D
30.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry MedStar authors:
  • Atkins, Francis
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Plyku D, Hobbs FR, Srinivasan S, Atkins F, Van Nostrand D, Sgouros G
Local accession number:
  • 2015_188
31.
The Utility of "Blind" 131I treatments for differentiated thyroid cancer: an educational exhibit. MedStar authors:
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D
Local accession number:
  • 2013_234
32.
Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors:
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Hobbs R
  • Brown T
  • Byard J
  • Plyku D
  • Sgouros G
  • Van Nostrand D.
  • Wu D
Local accession number:
  • B201872
33.
The utility of "blind" 131I treatments for differentiated thyroid cancer (DTC): an educational exhibit MedStar authors:
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Elboga U, Zeki C, Aktolun C, Van Nostrand D
Local accession number:
  • 2013_8
34.
Detection of 131I in public places: a national survey. MedStar authors:
  • Orquiza, Michael H
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Van Nostrand D,Orquiza M, Bloom G
Local accession number:
  • 2014.1_131
35.
The use of diuretics for increasing radioiodine (RAI) uptake in patients with well-differentiated thyroid cancer MedStar authors:
  • Orquiza, Michael H
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Van Nostrand D
Local accession number:
  • 2014.1_135
36.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
  • Atkins, Francis
  • Garcia, Carlos
  • Van Nostrand, Douglas
PMID:
  • 28104741
Year: 2017
Citation:
  • Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
37.
Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review] MedStar authors:
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Ylli, Dorina
PMID:
  • 30717901
Year: 2019
Citation:
  • Endocrinology & Metabolism Clinics of North America. 48(1):181-197, 2019 03.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D, Wartofsky L, Ylli D
38.
124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors:
  • Atkins, Francis
  • Garcia, Carlos
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D
Local accession number:
  • 2015_1
39.
124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors:
  • Atkins, Francis
  • Garcia, Carlos
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun 6
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D
Local accession number:
  • 2015_1
40.
The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors:
  • Elboga, Umut
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D
Local accession number:
  • 2013_160
41.
Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_162
42.
Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_236
43.
Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 28790138
Year: 2017
Citation:
  • Endocrine Connections. , 2017 Aug 08
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman K, Costello J, Jensen K, Klubo-Gwiezdzinska J, Patel A, Tkavc R, Van Nostrand D, Vasko V, Wartofsky L
44.
Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors:
  • Brown, Taneshea A
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2018
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Brown TA
  • Byard J
  • Hobbs R
  • Plyku D
  • Sgouros G
  • Van Nostrand D.
  • Wu D
Local accession number:
  • B2018454
45.
Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_161
46.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_235
47.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G
Local accession number:
  • 2013_7
48.
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. MedStar authors:
  • Garcia, Carlos
  • Plyku, Donika
  • Van Nostrand, Douglas
  • Wu, Di
PMID:
  • 35119623
Year: 2022
Citation:
  • Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D
49.
Nationwide survey on the changes in release of I-131 therapy patients after the implementation of the 2011 NRC regulatory policy. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Bloom G
  • Burman KD
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B2018640
50.
Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L
Local accession number:
  • 2013_7
51.
#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_159
52.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_233
53.
Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience. MedStar authors:
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Mete, Mihriye
  • Van Nostrand, Douglas
PMID:
  • 28553178
Year: 2017
Citation:
  • World Journal of Nuclear Medicine. 16(2):122-125, 2017 Apr-Jun
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Khorjekar G, Kulkarni K, Mete M, Van Nostrand D
54.
Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Ylli, Dorina
PMID:
  • 29741712
Year: 2018
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 103(5):1813-1817, 2018 May 01.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Van Nostrand D, Wartofsky L, Ylli D
55.
Checklist of criteria for the systematic assessment of patient-management guideline development. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Burman K
  • Turner D
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_573
56.
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
Local accession number:
  • 2013_166
57.
Whole body retention of 131I at 24hr versus 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors:
  • Atkins, Frank
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
Local accession number:
  • 2013_231
58.
Frequency, duration and severity of salivary side effects in DTC patients with onset at 3 to 12 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors:
  • Gomes Lima, Christiane J
  • Mete, Mihriye
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wu, Di
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Gomes Lima CJ
  • Hall JP
  • Khorjekar G
  • McIver B
  • Mete M
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_314
59.
124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Atkins F, Khorjekar G, Orquiza MD
Local accession number:
  • 2013_2
60.
Evaluation of the relationship of reproductive hormones to radioiodine breast uptake in patients with differentiated thyroid cancer: a pilot study. MedStar authors:
  • Kulkarni, Kanchan P
  • Kumar, Anagha
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Kulkarni K
  • Kumar A
  • Van Nostrand D.
  • Wu D
Local accession number:
  • B201870
61.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Duong E, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_7
62.
Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors:
  • Atkins, Frank
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Endocrinology
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Atkins F, Van Nostrand D, Orquiza M, Wartofsky L
Local accession number:
  • 2013_158
63.
Low-iodine diet and urine iodine measurements for 131-I treatments in patients with differentiated thyroid cancer: a comparison of 18 clinical practice guidelines. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman KD
  • Turner D
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_571
64.
Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen. MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 21876837
Year: 2011
Citation:
  • Journal of Thyroid Research. 2011:843591, 2011.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Klubo-Gwiezdzinska J, Van Nostrand D, Wartofsky L
65.
Amifostine used clinically for salivary gland protection during therapy with radioiodine is cytotoxic for thyroid cancer cells MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unpublished 2014 May 6
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Klubo-Gwiezdzinska J, Costello Jr J, Jensen K, Patel A, Van Nostrand D,Burman KD, Wartofsky L, Vasko V
Local accession number:
  • 2014.1_2
66.
The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: systematic review and meta-analysis. MedStar authors:
  • Burman, Kenneth D
  • Heimlich, Layla
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Burman K
  • Heimlich L
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B2018644
67.
Enhancing techniques for radioiodine imaging of differentiated thyroid cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Christiane J
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2018
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Burman K
  • Gomes-Lima CJ
  • Turner D
  • Van Nostrand D.
  • Wu D
Local accession number:
  • B2018647
68.
Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature. [Review] MedStar authors:
  • Burman, Kenneth D
  • Heimlich, Layla
  • Kulkarni, Kanchan
  • Van Nostrand, Douglas
  • Veytsman, Irina
PMID:
  • 36792922
Year: 2023
Citation:
  • Thyroid. 33(6):674-681, 2023 06.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Library
  • Medicine/Endocrinology
  • Radiology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Heimlich L, Kulkarni K, Van Nostrand D, Veytsman I
69.
Radioiodine refractory differentiated thyroid cancer classifications and evolution. MedStar authors:
  • Gomes-Lima, Christiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Burman K
  • Gomes-Lima CJ
  • Turner D
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_574
70.
Frequency, duration and severity of salivary effects in DTC patients with onset at 7 weeks to 3 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors:
  • Gomes Lima, Christiane J
  • Mete, Mihriye
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wu, Di
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Gomes Lima CJ
  • Hall JP
  • Khorjekar G
  • McIver B
  • Mete M
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_313
71.
How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit MedStar authors:
  • Bethancourt, E
  • Burman, Kenneth D
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2015_189
72.
I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors:
  • Atkins, Frank
  • Brown, Taneshea A
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Atkins FB
  • Brown TA
  • Frey EC
  • Lodge MA
  • Moreau SL
  • Plyku D
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_004
73.
Xerophthalmia and epiphora secondary to 131I therapy in patients with differentiated thyroid cancer: a prospective study. MedStar authors:
  • Burman, Kenneth D
  • Orquiza, Michael
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Orquiza M
  • Turner D
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_569
74.
Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_7
75.
Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth D
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 26357962
Year: 2015
Citation:
  • Thyroid. 25(12):1347-50, 2015 Dec.
Institution:
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Medicine/Nuclear Medicine
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Validation Studies
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L
76.
The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: a systematic review and meta-analysis. MedStar authors:
  • Burman, Kenneth D
  • Heimlich, Layla
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Library
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Heimlich SL
  • Burman K
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B201890
77.
Does pretreatment with lithium prior to radioactive iodine (RAI) therapy improve outcome in patients with metastatic differentiated thyroid cancer (DTC)? MedStar authors:
  • Burman, Kenneth D
  • Gomes Lima, Christiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Auh S
  • Breymaier M
  • Burman KD
  • Cochran C
  • et al.
  • Gomes-Lima CJ
  • Klubo-Gwiezdzinska J
  • Van Nostrand D
  • Wartofsky L
Local accession number:
  • A2017_312
78.
I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors:
  • Atkins, Frank
  • Brown, Taneshea A
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2017
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Atkins F
  • Brown T
  • Frey E
  • Lodge M
  • Moreau S
  • Plyku D
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_428
79.
Sialoadenitis and xerostomia secondary to I-131 therapy in patients with differentiated thyroid cancer and who took sialagogues: a prospective study. MedStar authors:
  • Burman, Kenneth D
  • Orquiza, Michael
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Burman K
  • Orquiza M
  • Turner D
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_576
80.
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_2
81.
Nationwide survey on the release of I-131 therapy patients to locations other than private residences. MedStar authors:
  • Bloom, Gary
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2019
Citation:
  • 2019/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Wu D, Bloom G, Burman K, Wartofsky L, Van Nostrand D.
Local accession number:
  • C2019_107
82.
Pretreatment with lithium may be associated with improved overall survival in patients undergoing dosimetry-based radioactive iodine treatment (RAI) for metastatic differentiated thyroid cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Christiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Auh S
  • Burman KD
  • Cochran C
  • et al.
  • Gomes-Lima C
  • Luo H
  • Tobey A
  • Van Nostrand D
  • Wartofsky L
  • Zemskova M
Local accession number:
  • A2017_572
83.
Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature. MedStar authors:
  • Burman, Kenneth D
  • Heimlich, Layla
  • Kulkarni, Kanchan
  • Van Nostrand, Douglas
  • Veytsman, Irina
PMID:
  • 36792922
Year: 2023
Citation:
  • Thyroid. 2023 Mar 21
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Library
  • Medicine/Endocrinology
  • Medstar Cancer Institute
  • Radiology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D, Veytsman I, Kulkarni K, Heimlich L, Burman KD
84.
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 22313411
Citation:
  • Thyroid. 22(3):310-7, 2012 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L
85.
Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?. MedStar authors:
  • Atkins, Francis
  • Kulkarni, Kanchan
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wexler, Jason
PMID:
  • 24177041
Citation:
  • Nuclear Medicine Communications. 35(2):210-6, 2014 Feb.
Medline publication type:
  • Clinical Trial
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Kulkarni K, Mete M, Van Nostrand D, Wartofsky L, Wexler J
86.
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
  • Bikas, A
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unpublished 2015 Mar 5
Institution:
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Form of publication:
  • Conference
All authors:
  • Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D
Local accession number:
  • 2014.1_1
87.
Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. [Review] MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 23186979
Year: 2013
Citation:
  • Endocrine Practice. 19(1):139-48, 2013 Jan-Feb.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L
88.
Lacrimal gland and nasolacrimal duct uptake on I-124 PET/CT imaging. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan P
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2019
Citation:
  • 2019/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Wu D, Kulkarni K, Burman K, Wartofsky L, Van Nostrand D.
Local accession number:
  • C2019_108
89.
Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer MedStar authors:
  • Bikas, A
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun 6
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K
Local accession number:
  • 2015_1
90.
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 31451488
Year: 2020
Citation:
  • Journal of Nuclear Medicine. 61(3):397-404, 2020 03.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bloom G, Burman KD, Gomes-Lima CJ, Van Nostrand D, Wartofsky L, Wu D
91.
I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: a review. MedStar authors:
  • Burman, Kenneth D
  • Heimlich, S Layla
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
  • Ylli, Dorina
PMID:
  • 31452449
Year: 2019
Citation:
  • Thyroid. 29(11):1523-1535, 2019 11.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Library
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Heimlich SL, Van Nostrand D, Wartofsky L, Wu D, Ylli D
92.
Selected Radiation Safety Aspects including Transportation and Lodging after Outpatient <sup>131</sup>I Therapy for Differentiated Thyroid Cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane Jeyce
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 29132255
Year: 2017
Citation:
  • Thyroid. , 2017 Nov 13
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bloom G, Burman KD, Gomes-Lima CJ, Kharazi PH, Khorjekar G, Ringel MD, Van Nostrand D, Vetter RJ, Wartofsky L, Wu D
93.
The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors:
  • Bethancourt, E
  • Burman, Kenneth D
  • Garcia, Carlos
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wexler, Jason
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l
Local accession number:
  • 2015_192
94.
A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors:
  • Brennan, Michael T
  • Hall, Jordan
  • Khorjekar, Gauri
  • Van Nostrand, Douglas
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Hall J
  • Khorjekar G
  • McIver B
  • Van Nostrand D
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_050
95.
Poor patient compliance with instructions for continuous sialogogues after <sup>131</sup> I therapy. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 30169900
Year: 2019
Citation:
  • Oral Diseases. 25(1):158-163, 2019 Jan.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Kharazi P, Khorjekar G, Kulkarni K, Moreau S, Van Nostrand D, Wartofsky L, Wu D
96.
Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer. MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 26649977
Year: 2016
Citation:
  • Thyroid. 26(2):280-6, 2016 Feb
Institution:
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bikas A, Burman KD, Desale S, Jensen K, Mete M, Patel A, Van Nostrand D, Vasko V, Wartofsky L
97.
Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer MedStar authors:
  • Bikas, A
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K
Local accession number:
  • 2015_1
98.
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
  • Bikas, A
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Mar 5
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D
Local accession number:
  • 2015_207
99.
Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan P
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Kharazi P
  • Khorjekar G
  • Kulkarni K
  • Moreau S
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B2018215
100.
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
  • Bethancourt, E
  • Bikas, A
  • Burman, Kenneth D
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
Local accession number:
  • 2015_191
Pages

Powered by Koha